Table 5 Responses to questionnaire on modified package leaflet supplemented with p-values (statins with placebo comparison)
Extract of questionnaire | |||||
|---|---|---|---|---|---|
Frequency of muscle pain that was reported in clinical trials on statins: | |||||
Statins | Placebo | p-value | |||
Cochrane 2013 N = 37,938, primary prevention | 9.5 % | 9.2 % | 0.40 | ||
Finegold 2014 N = 46,262, primary prevention | 7.9 % | 7.6 % | 0.407 | ||
Finegold 2014 N = 37,618, secondary prevention | 4.8 % | 4.6 % | 0.558 | ||
Question: If 100 patients take this statin – in how many of them does the intake of this statin cause muscle pain?a | |||||
Responses (No) | 0 | 1 | >1 | >10 | No response |
Format multiple choice | |||||
Group 6 (n = 87) Pharmacy group | 10 (12 %) | 12 (14 %) | 48 (55 %) | 14 (16 %) | 3 (3 %) |